Rho signaling inhibitor, Y-27632, inhibits invasiveness of metastastic hepatocellular carcinoma in a mouse model

Chinese Medical Journal

Volumn 120, Issue 24, 2007, Pages 2304-2307

  Xue, Feng ^a   Zhang, Jian Jun ^a   Qiu, Feng ^a   Zhang, Ming ^a   Chen, Xiao Song ^a   Li, Qi Gen ^a   Han, Long Zhi ^a   Xi, Zhi Feng ^a   Xia, Qiang ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Apoptosis; Hepatocellular carcinoma; Invasiveness; Metastasis; ROCK inhibitor

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; RHO FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER INVASION; CELL ASSAY; CELL STRUCTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HISTOPATHOLOGY; IMMUNOBLOTTING; LIVER CELL CARCINOMA; METASTASIS POTENTIAL; MOUSE; NONHUMAN; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN TARGETING; SIGNAL TRANSDUCTION;

EID: 38349191653     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200712020-00028     Document Type: Article

References (15)

1. Tang ZY. Hepatocellular carcinoma: cause, treatment and metastasis. World J Gastroenterol 2001; 7: 445-454.
2. Sahai E, Marshall CJ. Differing modes of tumor cell invasion have distinct requirements for Rho/ROCK signaling and extracellular proteolysis. Nat Cell Biol 2003; 5: 711-719.
3. Kusama T, Mukai M, Endo H, Ishikawa O, Tatsuta M, Nakamura H, et al. Inactivation of Rho GTPases by p190 RhoGAP reduces human pancreatic cell invasion and metastasis. Cancer Sci 2006; 97: 848-853.
4. Croft DR, Sahai E, Mavria G, Li S, Tsai J, Lee WM, et al. Conditional ROCK activation in vivo induces tumor cell dissemination and angiogenesis. Cancer Res 2004; 64: 8994-9001.
5. Takamura M, Sakamoto M, Genda T, Ichida T, Asakura H, Hirosashi S. Inhibition of intrahepatic metastasis of human hepatocellular carcinoma by Rho-associated protein kinase inhibitor Y-27632. Hepatology 2001; 33: 577-581.
6. Itoh K, Yoshioka K, Akedo H, Uehata M, Ishizaki T, Narumiya S. An essential part for Rho-associated kinase in the transcellular invasion of tumor cells. Nat Med 1999; 5: 221-225.
7. Mukai M, Endo H, Iwasaki Tatsuta M, Togawa A, Nakamura H, et al. RhoC is essential for TGF-beta1-induced invasive capacity of rat ascites hepatoma cells. Biochem Biophys Res Commun 2006; 346: 74-82.
8. Bartolome RA, Molina-Ortiz I, Samaniego R, Sanchez-Mateos P, Bustelo XR, Teixido J. Activation of Vav/Rho GTPase signaling by CXCL12 controls Membrane-type matrix metalloproteinase-dependent melanoma cell invasion. Cancer Res 2006; 66: 248-258.
9. Sawada S, Murakami K, Yamaura T, Mitani N, Tsukada K, Saiki I. Therapeutic and analysis model of intrahepatic metastasis reflects clinical behavior of hepatocellular carcinoma. Jpn J Cancer Res 2002; 93: 190-197.
10. Horiuchi A, Imai T, Wang C, Ohira S, Feng Y, NiKaido T, et al. Up-regulation of small GTPases, RhoA and RhoC, is associated with tumor progression in ovarian carcinoma. Lab Invest 2003; 83: 861-870.
11. Simpson KJ, Dugan AS, Mercurio AM. Functional analysis of the contribution of RhoA and RhoC GTPases to invasive breast carcinoma. Cancer Res 2004; 64: 8694-8701.
12. Faried A, Faried LS, Kimura H, Nakajima M, Sohda M, Miyazaki T, et al. RhoA and RhoC proteins promotes both cell proliferation and cell invasion of human oesophageal squamous cell carcinoma cell lines in vitro and in vivo. Eur J Cancer 2006; 42: 1455-1465.
13. Rattan R, Giri S, Singh AK, Singh I. Rho/ROCK pathway as a target for tumor therapy. J Neurosci Res 2006; 83: 243-255.
14. Benitah SA, Valeron PF, Lacal JC. ROCK and nuclear factor-kappa B-dependent activation of cyclooxygenase-2 by Rho GTPases: effects on tumor growth and therapeutic consequences. Mol Biol Cell 2003; 14: 3041-3054.
15. Ogawa T, Tashiro H, Miyata Y, Ushitora Y, Fudabe Y, Kobayashi T, et al. Rho-associated kinase inhibitor reduces tumor recurrence after liver transplantation in a rat hepatoma model. Am J Transplant 2007; 7: 347-355.